Learn about the current clinical applications of liquid biopsies, associated reimbursement issues, and what you can do to implement these tests at your program.
Find the CANCER BUZZ podcast on Apple Podcasts, Spotify, or wherever you get your podcasts!
Five years ago, the FDA approved the first liquid biopsy test for use in patients with cancer, providing cancer teams and patients a less invasive and more efficient way to detect disease. But liquid biopsies aren’t cheap, and reimbursement for them can be unpredictable and confusing.
On this episode of CANCER BUZZ, learn about the current clinical applications of liquid biopsies, associated reimbursement issues, and what you can do to implement these tests at your program.
Guests:
Related Content:
The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Cancer Care Centers.
September 10, 2026
An at-home option for cervical cancer screening breaks down barriers to care and offers the same level of precision as screening in the clinic.
